Cargando…
RETINAL BLOOD FLOW AFTER INTRAVITREAL BEVACIZUMAB IS A PREDICTIVE FACTOR FOR OUTCOMES OF MACULAR EDEMA ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSION
PURPOSE: To investigate whether retinal blood flow levels after intravitreal bevacizumab (IVB) treatment are correlated with the outcomes of patients with macular edema secondary to central retinal vein occlusion. METHODS: This retrospective observational case study enrolled 44 cases nonischemic cen...
Autores principales: | Matsumoto, Makiko, Suzuma, Kiyoshi, Yamada, Yoshihisa, Tsuiki, Eiko, Fujikawa, Azusa, Kitaoka, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Retina
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841858/ https://www.ncbi.nlm.nih.gov/pubmed/28151838 http://dx.doi.org/10.1097/IAE.0000000000001531 |
Ejemplares similares
-
Retro-mode imaging of fibrovascular membrane in proliferative diabetic retinopathy after intravitreal bevacizumab injection
por: Suzuma, Kiyoshi, et al.
Publicado: (2011) -
Retinal Microvascular Resistance Estimated from Waveform Analysis Is Significantly Higher With a Threshold Value in Central Retinal Vein Occlusion
por: Matsumoto, Makiko, et al.
Publicado: (2020) -
Retinal Vascular Resistance Significantly Correlates With Visual Acuity After 1 Year of Anti-VEGF Therapy in Central Retinal Vein Occlusion
por: Matsumoto, Makiko, et al.
Publicado: (2021) -
Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
por: Gutiérrez, Juan Carlos Mesa, et al.
Publicado: (2008) -
Oral kallidinogenase improved visual acuity and maintained chorioretinal blood flow levels after treatment for diabetic macular edema
por: Tsuiki, Eiko, et al.
Publicado: (2018)